Literature DB >> 15660433

Serum alanine aminotransferase in skeletal muscle diseases.

Rahul A Nathwani1, Shireen Pais, Telfer B Reynolds, Neil Kaplowitz.   

Abstract

Although elevation of the levels of serum alanine aminotransferase (ALT) following liver injury is well known, confusion exists concerning skeletal muscle injury as the cause of this rise. We reviewed the records of 16 patients who had muscle necrosis without evidence of liver disease. The patients were divided into three groups: extreme exercise, polymyositis, and seizures. All patients exhibited markedly elevated creatine kinase and lactate dehydrogenase levels consistent with muscle injury. In acute cases, aspartate aminotransferase (AST) and ALT were both elevated, and the AST/ALT ratio was greater than 3, but this ratio approached 1 after a few days because of a faster decline in AST. In conclusion, this difference in half-life accounts for the comparable AST and ALT levels in our cases with chronic muscle injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660433     DOI: 10.1002/hep.20548

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  77 in total

Review 1.  Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications.

Authors:  Young-Eun Cho; Byoung-Joon Song; Mohammed Akbar; Moon-Chang Baek
Journal:  Pharmacol Ther       Date:  2018-04-03       Impact factor: 12.310

2.  Elevated liver enzymes indicating a diagnosis of limb-girdle muscular dystrophy.

Authors:  Tyler Lash; Ryan R Kraemer
Journal:  J Gen Intern Med       Date:  2014-01-23       Impact factor: 5.128

Review 3.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

4.  Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2014-08       Impact factor: 3.199

5.  All that glitters is not gold: elevated liver enzymes do not mean liver disease always.

Authors:  Jeyamani Ramachandran; K G Sajith
Journal:  Indian J Gastroenterol       Date:  2014-01-14

6.  Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease.

Authors:  Marieke Hoeksma; Maartje Boon; Klary E Niezen-Koning; Lidy van Overbeek-van Gils; Francjan J van Spronsen
Journal:  Eur J Pediatr       Date:  2006-10-17       Impact factor: 3.183

Review 7.  The de ritis ratio: the test of time.

Authors:  Mona Botros; Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2013-11

8.  Effect of liver ischemia-reperfusion injury on the activity of neurons in the rat brain.

Authors:  Zdeno Pirnik; Jana Bundzikova; Tomas Francisty; Elena Cibulova; Lubica Lackovicova; Boris Mravec; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

9.  Circulating microRNAs in drug safety assessment for hepatic and cardiovascular toxicity: the latest biomarker frontier?

Authors:  Mitsuhiko Osaki; Nobuyoshi Kosaka; Futoshi Okada; Takahiro Ochiya
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

10.  A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Oleg A Shchelochkov; Mary A Mullins; Susan Carter; Brendan C Lanpher; Qin Sun; Soledad Kleppe; Ayelet Erez; E O'Brian Smith; Juan C Marini; Brendan Lee
Journal:  Mol Genet Metab       Date:  2012-09-17       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.